🇺🇸 FDA

Intelligence · INN Directory

Pharmaceutical Drugs

Regulatory status, brand names, and pipeline context for BD, medical affairs, and competitive intelligence teams.

Drugs indexed
4,797
Companies
1,769
Pipeline programs
20,548

Quick answer

NovaPharmaNews tracks 4,797 pharmaceutical drugs by INN (International Nonproprietary Name), with US FDA approval status, brand names, originators, routes of administration, and links to pipeline programs and patents. Search by generic name or browse A–Z for competitive intelligence and medical affairs reference.

Showing page 97 of 200 · A–Z by INN

  1. infliximab-axxq

    AVSOLA

    INJECTION FDA: approved

  2. infliximab-dyyb

    ZYMFENTRA

    INJECTION FDA: approved

  3. infliximab-qbtx

    IXIFI

    INJECTION FDA: approved

  4. influenza mrna vaccine

    MCOMBRIAX Teva Pharma GmbH

    EMA: approved

    J07B

  5. influenza vaccine (h1n1)v (split virion, inactivated, adjuvanted)

    PANDEMRIX

    EMA: unknown

    J07BB02

  6. influenza vaccine (h1n1)v (whole virion, vero cell derived, inactivated)

    CELVAPAN

    EMA: withdrawn

    J07BB01

  7. influenza vaccine (live attenuated, nasal)

    FLUENZ TETRA

    EMA: approved

    J07BB03

  8. influenza vaccine (split virion, inactivated)

    INTANZA

    EMA: withdrawn

    J07BB02

  9. influenza vaccine (surface antigen, inactivated, adjuvanted)

    FLUAD TETRA

    EMA: approved

    J07BB02

  10. influenza vaccine (surface antigen, inactivated, prepared in cell cultures)

    FLUCELVAX

    EMA: approved

    J07BB02

  11. influenza vaccine h1n1v (surface antigen, inactivated, adjuvanted)

    FOCETRIA

    EMA: unknown

    J07BB02

  12. infusion

    NMPA: clinical trials

  13. ingenol mebutate

    PICATO

    TOPICAL FDA: approved · EMA: withdrawn

    D06BX02

  14. inhalation

    NMPA: clinical trials

  15. inhalations

    NULL

    TGA: approved

  16. inhibitor

    NMPA: clinical trials

  17. inhibitors

    NMPA: clinical trials

  18. injectable

    NMPA: clinical trials

  19. injection

    NMPA: clinical trials

  20. inotersen

    TEGSEDI

    EMA: approved

    N07

  21. inotersen sodium

    TEGSEDI

    SUBCUTANEOUS FDA: approved

  22. inotuzumab ozogamicin

    BESPONSA Pfizer Australia Pty Ltd

    FDA: approved · EMA: approved · TGA: approved · PMDA: approved

    L01FB01

  23. insulin

    NMPA: clinical trials

  24. insulin aspart

    FIASP PENFILL NovoThirteen

    SUBCUTANEOUS FDA: approved · EMA: approved · TGA: approved

    A10AB05

Frequently asked questions

What is the NovaPharmaNews drugs directory?

It is a searchable index of 4,797 pharmaceutical active ingredients and their marketed profiles — INN, brand names, US regulatory status, manufacturers, and cross-links to clinical pipeline and patent records.

Where does drug approval data come from?

Profiles combine FDA Drugs@FDA and Orange Book references, ClinicalTrials.gov pipeline links, and editorial enrichment. See our data sources page for attribution and update cadence. This directory is for professional reference, not medical advice.

How do I find a drug by brand name?

Use the search box on this page — it matches both INN (generic name) and slug. Brand names appear on each drug row and on the full drug profile page, with links to the originator company when available.

Data attribution and licensing: Data sources